{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T06:15:50Z","timestamp":1778739350652,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T00:00:00Z","timestamp":1525478400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Community Health"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s10900-018-0517-x","type":"journal-article","created":{"date-parts":[[2018,5,5]],"date-time":"2018-05-05T06:17:56Z","timestamp":1525501076000},"page":"1019-1027","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Assessing and Improving Zoster Vaccine Uptake in a Homeless Population"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5074-8672","authenticated-orcid":false,"given":"Laura","family":"Kaplan-Weisman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eve","family":"Waltermaurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey","family":"Crump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,5]]},"reference":[{"issue":"1","key":"517_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1378\/chest.99.1.147","volume":"99","author":"A Mercat","year":"1991","unstructured":"Mercat, A., Nguyen, J., & Dautzenberg, B. (1991). An outbreak of pneumococcal pneumonia in two men\u2019s shelters. Chest, 99(1), 147\u2013151.","journal-title":"Chest"},{"issue":"1","key":"517_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/SMJ.0b013e3181c46f79","volume":"103","author":"P Wiersma","year":"2010","unstructured":"Wiersma, P., Epperson, S., Terp, S., et al. (2010). Episodic illness, chronic disease, and health care use among homeless persons in Metropolitan Atlanta, Georgia, 2007. Southern Medical Journal, 103(1), 18\u201324.","journal-title":"Southern Medical Journal"},{"issue":"9","key":"517_CR3","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3201\/eid1409.080204","volume":"14","author":"S Badiaga","year":"2008","unstructured":"Badiaga, S., Raoult, D., & Brouqui, P. (2008). Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerging Infectious Diseases, 14(9), 1353\u20131359.","journal-title":"Emerging Infectious Diseases"},{"key":"517_CR4","unstructured":"Shingles (Herpes Zoster) Vaccination. (2017, August 9). CDC. Retrieved from https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/index.html ."},{"key":"517_CR5","unstructured":"Shingles (Herpes Zoster) | For Health Care Professionals. (2017, October 25). CDC. Retrieved from https:\/\/www.cdc.gov\/shingles\/hcp\/index.html ."},{"issue":"11","key":"517_CR6","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMe1610652","volume":"375","author":"KM Neuzil","year":"2016","unstructured":"Neuzil, K. M., & Griffin, M. R. (2016). Preventing shingles and its complications in older persons. New England Journal of Medicine, 375(11), 1079\u20131080.","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"517_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss6611a1","volume":"66","author":"WW Williams","year":"2017","unstructured":"Williams, W. W., Lu, P.-J., O\u2019Halloran, A., et al. (2017). Surveillance of vaccination coverage among adult populations\u2014United States, 2015. MMWR. Surveillance Summaries, 66(11), 1\u201328.","journal-title":"MMWR. Surveillance Summaries"},{"issue":"1","key":"517_CR8","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/j.amepre.2016.08.029","volume":"52","author":"D Zhang","year":"2017","unstructured":"Zhang, D., Johnson, K., Newransky, C., & Acosta, C. J. (2017). Herpes zoster vaccine coverage in older adults in the U.S., 2007\u20132013. American Journal of Preventive Medicine, 52(1), e17\u2013e23.","journal-title":"American Journal of Preventive Medicine"},{"issue":"2","key":"517_CR9","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40273-012-0020-7","volume":"31","author":"TD Szucs","year":"2013","unstructured":"Szucs, T. D., & Pfeil, A. M. (2013). A systematic review of the cost effectiveness of herpes zoster vaccination. PharmacoEconomics, 31(2), 125\u2013136.","journal-title":"PharmacoEconomics"},{"issue":"15","key":"517_CR10","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.vaccine.2014.01.058","volume":"32","author":"K Kawai","year":"2014","unstructured":"Kawai, K., Preaud, E., Baron-Papillon, F., Largeron, N., & Acosta, C. J. (2014). Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: A critical review. Vaccine, 32(15), 1645\u20131653.","journal-title":"Vaccine"},{"issue":"49","key":"517_CR11","doi-asserted-by":"publisher","first-page":"8326","DOI":"10.1016\/j.vaccine.2007.09.066","volume":"25","author":"JM Pellissier","year":"2007","unstructured":"Pellissier, J. M., Brisson, M., & Levin, M. J. (2007). Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. Vaccine, 25(49), 8326\u20138337.","journal-title":"Vaccine"},{"key":"517_CR12","unstructured":"Elkin, Z. (2013, October 10). Barriers to translating evidence into clinical care: the zoster vaccine. The NYU Langone Online Journal of Medicine. Retrieved from https:\/\/www.clinicalcorrelations.org\/?p=6518 ."},{"issue":"9","key":"517_CR13","doi-asserted-by":"publisher","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","volume":"152","author":"LP Hurley","year":"2010","unstructured":"Hurley, L. P., Lindley, M. C., Harpaz, R., et al. (2010). Barriers to the use of herpes zoster vaccine. Annals of Internal Medicine, 152(9), 555\u2013560.","journal-title":"Annals of Internal Medicine"},{"issue":"Supplement_2","key":"517_CR14","doi-asserted-by":"publisher","first-page":"S216","DOI":"10.1086\/522153","volume":"197","author":"LP Hurley","year":"2008","unstructured":"Hurley, L. P., Harpaz, R., Daley, M. F., et al. (2008). National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine. The Journal of Infectious Diseases, 197(Supplement_2), S216\u2013S223.","journal-title":"The Journal of Infectious Diseases"},{"issue":"9","key":"517_CR15","first-page":"e309-313","volume":"19","author":"MS Taitel","year":"2013","unstructured":"Taitel, M. S., Fensterheim, L. E., Cannon, A. E., & Cohen, E. S. (2013). Improving pneumococcal and herpes zoster vaccination uptake: Expanding pharmacist privileges. The American Journal of Managed Care, 19(9), e309-313.","journal-title":"The American Journal of Managed Care"},{"key":"517_CR16","unstructured":"Carr, T. (2017, April 28). Why does my shingles vaccine cost so much? Consumer Reports. Retrieved from https:\/\/www.consumerreports.org\/health\/why-the-shingles-vaccine-cost-so-much\/ ."},{"issue":"ja","key":"517_CR17","first-page":"1","volume":"0","author":"S Yan","year":"2017","unstructured":"Yan, S., DerSarkissian, M., Bhak, R. H., Lefebvre, P., Duh, M. S., & Krishnarajah, G. (2017). Relationship between patient copayments in Medicare Part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis. Current Medical Research and Opinion, 0(ja), 1\u201326.","journal-title":"Current Medical Research and Opinion"},{"issue":"4","key":"517_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/pharmacy4040030","volume":"4","author":"K Montag Schafer","year":"2016","unstructured":"Montag Schafer, K., & Reidt, S. (2016). Assessment of perceived barriers to herpes zoster vaccination among geriatric primary care providers. Pharmacy, 4(4), 30.","journal-title":"Pharmacy"},{"issue":"7","key":"517_CR19","doi-asserted-by":"publisher","first-page":"A592","DOI":"10.1016\/j.jval.2015.09.1528","volume":"18","author":"O Damm","year":"2015","unstructured":"Damm, O., Witte, J., & Greiner, W. (2015). A systematic review of herpes zoster vaccine acceptance. Value in Health, 18(7), A592.","journal-title":"Value in Health"},{"key":"517_CR20","unstructured":"Medicare Part D Vaccines and Vaccine Administration. (2018, January). Medicare Learning Network. Retrieved from https:\/\/www.cms.gov\/Outreach-and-Education\/Medicare-Learning-Network-MLN\/MLNProducts\/Downloads\/Vaccines-Part-D-Factsheet-ICN908764.pdf\/ ."},{"issue":"2","key":"517_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1177\/003335491613100216","volume":"131","author":"LP Hurley","year":"2016","unstructured":"Hurley, L. P., Bridges, C. B., Harpaz, R., et al. (2016). Physician attitudes toward adult vaccines and other preventive practices, United States, 2012. Public Health Reports, 131(2), 320\u2013330.","journal-title":"Public Health Reports"},{"issue":"0","key":"517_CR22","first-page":"1","volume":"0","author":"EM La","year":"2017","unstructured":"La, E. M., Trantham, L., Kurosky, S. K., Odom, D., Aris, E., & Hogea, C. (2017). An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability. Human Vaccines & Immunotherapeutics, 0(0), 1\u201312.","journal-title":"Human Vaccines & Immunotherapeutics"},{"issue":"3","key":"517_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.amepre.2016.08.031","volume":"52","author":"P-J Lu","year":"2017","unstructured":"Lu, P.-J., O\u2019Halloran, A., Williams, W. W., & Harpaz, R. (2017). National and state-specific shingles vaccination among adults aged \u2265 60 years. American Journal of Preventive Medicine, 52(3), 362\u2013372.","journal-title":"American Journal of Preventive Medicine"},{"issue":"1","key":"517_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3122\/jabfm.2013.01.120154","volume":"26","author":"TJ Lee","year":"2013","unstructured":"Lee, T. J., Hayes, S., Cummings, D. M., et al. (2013). Herpes zoster knowledge, prevalence, and vaccination rate by race. The Journal of the American Board of Family Medicine, 26(1), 45\u201351.","journal-title":"The Journal of the American Board of Family Medicine"},{"issue":"1","key":"517_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1331\/JAPhA.2013.12019","volume":"53","author":"J Wang","year":"2013","unstructured":"Wang, J., Ford, L. J., Wingate, L., et al. (2013). The effect of pharmacist intervention on herpes zoster vaccination in community pharmacies. Journal of the American Pharmacists Association, 53(1), 46\u201353.","journal-title":"Journal of the American Pharmacists Association"},{"issue":"1","key":"517_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1331\/JAPhA.2009.08030","volume":"49","author":"HM Wood","year":"2009","unstructured":"Wood, H. M., McDonough, R. P., & Doucette, W. R. (2009). Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective. Journal of the American Pharmacists Association, 49(1), 12\u201317.","journal-title":"Journal of the American Pharmacists Association"},{"issue":"4","key":"517_CR27","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1331\/JAPhA.2014.13140","volume":"54","author":"MA Hedden","year":"2014","unstructured":"Hedden, M. A., Kuehl, P. G., & Liu, Y. (2014). Economic analysis of a herpes zoster vaccination program in 19 affiliated supermarket pharmacies. Journal of the American Pharmacists Association, 54(4), 390\u2013396.","journal-title":"Journal of the American Pharmacists Association"},{"issue":"3S","key":"517_CR28","doi-asserted-by":"publisher","first-page":"S293","DOI":"10.1016\/j.japh.2017.02.007","volume":"57","author":"BW Bedwick","year":"2017","unstructured":"Bedwick, B. W., Garofoli, G. K., & Elswick, B. M. (2017). Assessment of targeted automated messages on herpes zoster immunization numbers in an independent community pharmacy. Journal of the American Pharmacists Association, 57(3S), S293\u2013S297.e1.","journal-title":"Journal of the American Pharmacists Association"},{"issue":"2","key":"517_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1331\/JAPhA.2013.12222","volume":"53","author":"R Hess","year":"2013","unstructured":"Hess, R. (2013). Impact of automated telephone messaging on zoster vaccination rates in community pharmacies. Journal of the American Pharmacists Association, 53(2), 182\u2013187.","journal-title":"Journal of the American Pharmacists Association"},{"key":"517_CR30","unstructured":"APhA Honors 2014 Immunization Champions. (2014, May 29). American Pharmacists Association. Retrieved January 1, 2018, from http:\/\/www.pharmacist.com\/apha-honors-2014-immunization-champions\/ ."},{"issue":"1","key":"517_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1331\/JAPhA.2013.11097","volume":"53","author":"AR Bryan","year":"2013","unstructured":"Bryan, A. R., Liu, Y., & Kuehl, P. G. (2013). Advocating zoster vaccination in a community pharmacy through use of personal selling. Journal of the American Pharmacists Association, 53(1), 70\u201377.","journal-title":"Journal of the American Pharmacists Association"},{"issue":"9","key":"517_CR32","doi-asserted-by":"publisher","first-page":"832.e1","DOI":"10.1016\/j.amjmed.2013.02.018","volume":"126","author":"SH Otsuka","year":"2013","unstructured":"Otsuka, S. H., Tayal, N. H., Porter, K., Embi, P. J., & Beatty, S. J. (2013). Improving herpes zoster vaccination rates through use of a clinical pharmacist and a personal health record. The American Journal of Medicine, 126(9), 832.e1\u2013832.e6.","journal-title":"The American Journal of Medicine"},{"issue":"2","key":"517_CR33","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-2753.2011.01814.x","volume":"19","author":"R Chaudhry","year":"2013","unstructured":"Chaudhry, R., Schietel, S. M., North, F., Dejesus, R., Kesman, R. L., & Stroebel, R. J. (2013). Improving rates of herpes zoster vaccination with a clinical decision support system in a primary care practice. Journal of Evaluation in Clinical Practice, 19(2), 263\u2013266.","journal-title":"Journal of Evaluation in Clinical Practice"},{"issue":"7","key":"517_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/2327-6924.12459","volume":"29","author":"WL Wright","year":"2017","unstructured":"Wright, W. L., Morrell, E., Lee, J., Cuellar, N. G., & White, P. (2017). Comparison of immunization rates of adults ages 65 years and older managed within two nurse practitioner\u2013owned clinics with national immunization rates. Journal of the American Association of Nurse Practitioners, 29(7), 384\u2013391.","journal-title":"Journal of the American Association of Nurse Practitioners"},{"issue":"5","key":"517_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ajo.2012.11.022","volume":"155","author":"JJ Jung","year":"2013","unstructured":"Jung, J. J., Elkin, Z. P., Li, X., et al. (2013). Increasing use of the vaccine against zoster through recommendation and administration by ophthalmologists at a city hospital. American Journal of Ophthalmology, 155(5), 787\u2013795.e2.","journal-title":"American Journal of Ophthalmology"},{"key":"517_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1186\/s12889-016-3107-9","volume":"16","author":"AM Sevin","year":"2016","unstructured":"Sevin, A. M., Romeo, C., Gagne, B., Brown, N. V., & Rodis, J. L. (2016). Factors influencing adults\u2019 immunization practices: A pilot survey study of a diverse, urban community in central Ohio. BMC Public Health, 16, 424\u2013424.","journal-title":"BMC Public Health"},{"issue":"6","key":"517_CR37","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.vaccine.2008.11.077","volume":"27","author":"P Lu","year":"2009","unstructured":"Lu, P., Euler, G. L., Jumaan, A. O., & Harpaz, R. (2009). Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors. Vaccine, 27(6), 882\u2013887.","journal-title":"Vaccine"},{"issue":"2","key":"517_CR38","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/phn.12088","volume":"31","author":"SE Metcalfe","year":"2014","unstructured":"Metcalfe, S. E., & Sexton, E. H. (2014). An academic-community partnership to address the flu vaccination rates of the homeless. Public Health Nursing, 31(2), 175\u2013182.","journal-title":"Public Health Nursing"},{"issue":"2","key":"517_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jama.285.2.200","volume":"285","author":"MB Kushel","year":"2001","unstructured":"Kushel, M. B., Vittinghoff, E., & Haas, J. S. (2001). Factors associated with the health care utilization of homeless persons. JAMA, 285(2), 200\u2013206.","journal-title":"JAMA"},{"issue":"7","key":"517_CR40","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.2105\/AJPH.2009.180109","volume":"100","author":"TP Baggett","year":"2010","unstructured":"Baggett, T. P., O\u2019Connell, J. J., Singer, D. E., & Rigotti, N. A. (2010). The unmet health care needs of homeless adults: A national study. American Journal of Public Health, 100(7), 1326\u20131333.","journal-title":"American Journal of Public Health"},{"key":"517_CR41","unstructured":"\u201cMinorities and Homelessness\u201d. National Coalition for the Homeless. (2009, July). Retrieved from http:\/\/www.nationalhomeless.org\/factsheets\/minorities.html\/ ."},{"key":"517_CR42","unstructured":"Immunizations and emergency treatment of anaphylaxis pursuant to patient specific and non-patient specific orders and protocols, New York Statute \u00a7 63.9. (Effective 2009, August 20, last updated 2017, August 9). Retrieved from http:\/\/www.op.nysed.gov\/prof\/pharm\/part63.htm#immunization ."},{"key":"517_CR43","unstructured":"Vaccine Ordering 101 |Order Merck Vaccines. (2015, March 16). Medical Group Purchasing Organization. Retrieved from http:\/\/www.mppg.net\/3-16-15-vaccine-ordering-101\/ ."},{"key":"517_CR44","unstructured":"Merck Programs to Help Those in Need - Product. (2018). Retrieved from http:\/\/www.merckhelps.com\/zostavax\/ ."},{"issue":"5","key":"517_CR45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF03404802","volume":"91","author":"CA Marra","year":"2000","unstructured":"Marra, C. A., Patrick, D. M., & Marra, F. (2000). A cost-effectiveness analysis of pneumococcal vaccination in street-involved, HIV-infected patients. Canadian Journal of Public Health, 91(5), 334\u2013339.","journal-title":"Canadian Journal of Public Health"},{"issue":"23","key":"517_CR46","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1016\/j.vaccine.2017.02.016","volume":"35","author":"W Prins","year":"2017","unstructured":"Prins, W., Butcher, E., Hall, L. L., Puckrein, G., & Rosof, B. (2017). Improving adult immunization equity: Where do the published research literature and existing resources lead? Vaccine, 35(23), 3020\u20133025.","journal-title":"Vaccine"},{"key":"517_CR47","first-page":"1327","volume":"2011","author":"MJ Stephens","year":"2011","unstructured":"Stephens, M. J., Finnell, J. T., Simonaitis, L., & Overhage, J. M. (2011). Variability in drug formularies and implications in decision support. AMIA Annual Symposium Proceedings, 2011, 1327\u20131336.","journal-title":"AMIA Annual Symposium Proceedings"},{"issue":"1","key":"517_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-016-1752-4","volume":"16","author":"C-W Tseng","year":"2016","unstructured":"Tseng, C.-W., Lin, G. A., Davis, J., et al. (2016). Giving formulary and drug cost information to providers and impact on medication cost and use: A longitudinal non-randomized study. BMC Health Services Research, 16(1), 1\u20138.","journal-title":"BMC Health Services Research"},{"key":"517_CR49","unstructured":"Crawford, C. (2017, October 31). ACIP recommends new herpes zoster subunit vaccine. Retrieved from https:\/\/www.aafp.org\/news\/health-of-the-public\/20171031acipmeeting.html\/ ."},{"issue":"11","key":"517_CR50","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham, A. L., Lal, H., Kovac, M., et al. (2016). Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. New England Journal of Medicine, 375(11), 1019\u20131032.","journal-title":"New England Journal of Medicine"},{"issue":"22","key":"517_CR51","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal, H., Cunningham, A. L., Godeaux, O., et al. C (2015). Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. New England Journal of Medicine, 372(22), 2087\u20132096.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"517_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.vaccine.2017.11.019","volume":"36","author":"H Lal","year":"2018","unstructured":"Lal, H., Poder, A., Campora, L., et al. (2018). Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study. Vaccine, 36(1), 148\u2013154.","journal-title":"Vaccine"},{"issue":"7","key":"517_CR53","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1093\/cid\/cix484","volume":"65","author":"M Eberhardson","year":"2017","unstructured":"Eberhardson, M., Hall, S., Papp, K. A., et al. (2017). Safety and Immunogenicity of inactivated varicella-zoster virus vaccine in adults with autoimmune disease: A phase 2, randomized, double-blind, placebo-controlled clinical trial. Clinical Infectious Diseases, 65(7), 1174\u20131182.","journal-title":"Clinical Infectious Diseases"},{"issue":"14","key":"517_CR54","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.vaccine.2016.10.055","volume":"35","author":"J Parrino","year":"2017","unstructured":"Parrino, J., McNeil, S. A., Lawrence, S. J., et al. (2017). Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies. Vaccine, 35(14), 1764\u20131769.","journal-title":"Vaccine"},{"key":"517_CR55","unstructured":"Shingrix Vaccine Storage and Handling. (2018, January 25). CDC. Retrieved from https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/hcp\/shingrix\/storage-handling.html\/ ."}],"container-title":["Journal of Community Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10900-018-0517-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-018-0517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10900-018-0517-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T11:05:28Z","timestamp":1571310328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10900-018-0517-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,5]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1007\/s10900-018-0517-x","relation":{},"ISSN":["0094-5145","1573-3610"],"issn-type":[{"value":"0094-5145","type":"print"},{"value":"1573-3610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,5]]},"assertion":[{"value":"5 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare we have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institute for Family Health Institutional Review Board, protocol 2222. Patients were not compensated for their participation in this study. Participant informed consent was obtained prior to administering the zoster vaccine but was not required for the retrospective chart review as this study used only de-identified secondary data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}